US 10,420,750 B2 · Device for delivery of a pharmaceutical composition

Abstract

The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.

Claims19

Dependent claims

A device for delivery of a pharmaceutical composition, wherein said device comprises a pharmaceutical composition comprising:

about 3% (w/v) tetracaine HCl;
about 0.05% oxymetazoline HCl;
and,
a pharmaceutically acceptable carrier;
wherein said device is a nasal spray device.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application

15/498,991Filed 27 Apr 2017 · continuation

Priority

3 Apr 2009

Published

US 2017/0326112 A116 Nov 2017

Granted

24 Sep 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/4164
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,3-Diazoles
A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 9/14
Medicinal preparations characterised by special physical form: particulate form, e.g. powders, Processes for size reducing of pure drugs or the…
A61K 31/245
Having an amino or nitro group: amino benzoic acid types, e.g. procaine, novocaine

Family

Application61/166,680Us provisional application · filed 3 Apr 2009

PCT/US2010/001002Parent of this continuation · filed 2 Apr 2010

Application14/027,033Parent of this continuation · filed 13 Sep 2013

US 8,580,282 B2Parent of this continuation · filed 12 Nov 2013

Application15/058,324Parent of this continuation · filed 2 Mar 2016

US 9,308,191 B2Parent of this continuation · filed 12 Apr 2016

US 2017/0326112 A1Pre-grant publication · published 16 Nov 2017

US 9,855,247 B2Parent of this continuation

Application13/262,704Parent of this continuation

US 2012/0039960 A1Published application

US 2014/0234421 A1Published application

US 2016/0184269 A1Published application

US 10,420,750 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

15/498,991Filed 27 Apr 2017 · continuation

Priority

3 Apr 2009

Published

US 2017/0326112 A116 Nov 2017

Granted

24 Sep 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/4164
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,3-Diazoles
A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 9/14
Medicinal preparations characterised by special physical form: particulate form, e.g. powders, Processes for size reducing of pure drugs or the…
A61K 31/245
Having an amino or nitro group: amino benzoic acid types, e.g. procaine, novocaine

Family

Application61/166,680Us provisional application · filed 3 Apr 2009

PCT/US2010/001002Parent of this continuation · filed 2 Apr 2010

Application14/027,033Parent of this continuation · filed 13 Sep 2013

US 8,580,282 B2Parent of this continuation · filed 12 Nov 2013

Application15/058,324Parent of this continuation · filed 2 Mar 2016

US 9,308,191 B2Parent of this continuation · filed 12 Apr 2016

US 2017/0326112 A1Pre-grant publication · published 16 Nov 2017

US 9,855,247 B2Parent of this continuation

Application13/262,704Parent of this continuation

US 2012/0039960 A1Published application

US 2014/0234421 A1Published application

US 2016/0184269 A1Published application

US 10,420,750 B2This patent

From the US filing history. Foreign family members aren’t listed.

Device for delivery of a pharmaceutical composition

Life of this patent

Abstract

Claims19

Device for delivery of a pharmaceutical composition

Life of this patent

Abstract

Claims19